INNOPHARMAX develops oral new dosage form new drugs for further clinical development and commercialization, utilizing core drug delivery technology platforms OralPAS®, OralPAS Pro®, and MUCR. We are committed to improve the safety and efficacy of currently available drugs, and provide superior and cost effective medical options.
,
Founded in unknown
11-50 employees
INNOPHARMAX develops oral new dosage form new drugs for further clinical development and commercialization, utilizing core drug delivery technology platforms OralPAS®, OralPAS Pro®, and MUCR. We are committed to improve the safety and efficacy of currently available drugs, and provide superior and cost effective medical options.
Company Information
- Industry
- Company Type
- Public Company
- Founded
- unknown
- Employee Range
- 11-50
- Revenue Range
- Not available
Location
- Address
- 11492 Taipei
- City
- Region
- Postal Code
- Country
- Taiwan
Web Presence
Websiteinnopharmax.com
LinkedIn0 followers